| Bora Toklu, MD | |
|
142 Palisade Ave Ste 115, Jersey City, NJ 07306-1108 | |
| (844) 211-2273 | |
| Not Available |
| Full Name | Bora Toklu |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 18 Years |
| Location | 142 Palisade Ave Ste 115, Jersey City, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508019456 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0011X | Internal Medicine - Interventional Cardiology | 25MA10639300 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hoboken University Medical Center | Hoboken, NJ | Hospital |
| Carepoint Health-christ Hospital | Jersey city, NJ | Hospital |
| Bayonne Medical Center | Bayonne, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Garden State Healthcare Associates Llc | 8426190687 | 149 |
| New Jersey Medical And Health Associates Llc | 9133300791 | 68 |
News Archive
Opexa Therapeutics, Inc., a company developing a novel T-cell therapy for multiple sclerosis (MS), announced today that the Company has been selected to present key efficacy data at the upcoming American Academy of Neurology (AAN) 62nd Annual Meeting to be held in Toronto, Canada.
Patients with diabetes-associated wounds could receive faster and more effective treatment thanks to a non-invasive device that monitors wound healing and is one step closer to market. Emunamedica LLC, a Florida-based healthcare start-up, has licensed technology for a near-infrared wound monitor from Drexel University. The device was developed by Dr. Elisabeth Papazoglou and Dr. Leonid Zubkov of Drexel's School of Biomedical Engineering, Science and Health Systems in collaboration with Dr. Michael S. Weingarten, M.D. of Drexel College of Medicine and their teams.
Aniak, Alaska, is a Yu'pik village of 500 people on the Yukon-Kuskokwim delta, about 400 miles northwest of Anchorage. It is in this special and isolated community where I practice as a dental therapist, trained and certified to deliver some, but not all, types of dental care. Dental therapists have been practicing in Alaska for nine years and now provide routine dental care to 40,000 Native Alaskans. In the United States about forty-seven million people live in areas where there is a shortage of dentists, and millions more can't afford to see them. For so many Americans, even the most basic dental care is out of reach. Yet right here in Alaska, I think we've found part of the solution (Conan Murat, November, 2013).
HealthCom Media, a leading information and content development company specializing in marketing and publishing solutions that complement traditional advertising programs.
New data presented at the 2016 San Antonio Breast Cancer Symposium (SABCS) demonstrate that analyzing tumor biology with the Oncotype DX test can identify patients unlikely to benefit from chemotherapy prior to breast cancer surgery (neoadjuvant setting) and guide treatment decisions without compromising outcomes.
› Verified 6 days ago
| Entity Name | Garden State Healthcare Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700014545 PECOS PAC ID: 8426190687 Enrollment ID: O20100126000693 |
News Archive
Opexa Therapeutics, Inc., a company developing a novel T-cell therapy for multiple sclerosis (MS), announced today that the Company has been selected to present key efficacy data at the upcoming American Academy of Neurology (AAN) 62nd Annual Meeting to be held in Toronto, Canada.
Patients with diabetes-associated wounds could receive faster and more effective treatment thanks to a non-invasive device that monitors wound healing and is one step closer to market. Emunamedica LLC, a Florida-based healthcare start-up, has licensed technology for a near-infrared wound monitor from Drexel University. The device was developed by Dr. Elisabeth Papazoglou and Dr. Leonid Zubkov of Drexel's School of Biomedical Engineering, Science and Health Systems in collaboration with Dr. Michael S. Weingarten, M.D. of Drexel College of Medicine and their teams.
Aniak, Alaska, is a Yu'pik village of 500 people on the Yukon-Kuskokwim delta, about 400 miles northwest of Anchorage. It is in this special and isolated community where I practice as a dental therapist, trained and certified to deliver some, but not all, types of dental care. Dental therapists have been practicing in Alaska for nine years and now provide routine dental care to 40,000 Native Alaskans. In the United States about forty-seven million people live in areas where there is a shortage of dentists, and millions more can't afford to see them. For so many Americans, even the most basic dental care is out of reach. Yet right here in Alaska, I think we've found part of the solution (Conan Murat, November, 2013).
HealthCom Media, a leading information and content development company specializing in marketing and publishing solutions that complement traditional advertising programs.
New data presented at the 2016 San Antonio Breast Cancer Symposium (SABCS) demonstrate that analyzing tumor biology with the Oncotype DX test can identify patients unlikely to benefit from chemotherapy prior to breast cancer surgery (neoadjuvant setting) and guide treatment decisions without compromising outcomes.
› Verified 6 days ago
| Entity Name | New Jersey Medical And Health Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558673582 PECOS PAC ID: 9133300791 Enrollment ID: O20110302000334 |
News Archive
Opexa Therapeutics, Inc., a company developing a novel T-cell therapy for multiple sclerosis (MS), announced today that the Company has been selected to present key efficacy data at the upcoming American Academy of Neurology (AAN) 62nd Annual Meeting to be held in Toronto, Canada.
Patients with diabetes-associated wounds could receive faster and more effective treatment thanks to a non-invasive device that monitors wound healing and is one step closer to market. Emunamedica LLC, a Florida-based healthcare start-up, has licensed technology for a near-infrared wound monitor from Drexel University. The device was developed by Dr. Elisabeth Papazoglou and Dr. Leonid Zubkov of Drexel's School of Biomedical Engineering, Science and Health Systems in collaboration with Dr. Michael S. Weingarten, M.D. of Drexel College of Medicine and their teams.
Aniak, Alaska, is a Yu'pik village of 500 people on the Yukon-Kuskokwim delta, about 400 miles northwest of Anchorage. It is in this special and isolated community where I practice as a dental therapist, trained and certified to deliver some, but not all, types of dental care. Dental therapists have been practicing in Alaska for nine years and now provide routine dental care to 40,000 Native Alaskans. In the United States about forty-seven million people live in areas where there is a shortage of dentists, and millions more can't afford to see them. For so many Americans, even the most basic dental care is out of reach. Yet right here in Alaska, I think we've found part of the solution (Conan Murat, November, 2013).
HealthCom Media, a leading information and content development company specializing in marketing and publishing solutions that complement traditional advertising programs.
New data presented at the 2016 San Antonio Breast Cancer Symposium (SABCS) demonstrate that analyzing tumor biology with the Oncotype DX test can identify patients unlikely to benefit from chemotherapy prior to breast cancer surgery (neoadjuvant setting) and guide treatment decisions without compromising outcomes.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bora Toklu, MD 142 Palisade Ave Ste 115, Jersey City, NJ 07306-1108 Ph: (844) 211-2273 | Bora Toklu, MD 142 Palisade Ave Ste 115, Jersey City, NJ 07306-1108 Ph: (844) 211-2273 |
News Archive
Opexa Therapeutics, Inc., a company developing a novel T-cell therapy for multiple sclerosis (MS), announced today that the Company has been selected to present key efficacy data at the upcoming American Academy of Neurology (AAN) 62nd Annual Meeting to be held in Toronto, Canada.
Patients with diabetes-associated wounds could receive faster and more effective treatment thanks to a non-invasive device that monitors wound healing and is one step closer to market. Emunamedica LLC, a Florida-based healthcare start-up, has licensed technology for a near-infrared wound monitor from Drexel University. The device was developed by Dr. Elisabeth Papazoglou and Dr. Leonid Zubkov of Drexel's School of Biomedical Engineering, Science and Health Systems in collaboration with Dr. Michael S. Weingarten, M.D. of Drexel College of Medicine and their teams.
Aniak, Alaska, is a Yu'pik village of 500 people on the Yukon-Kuskokwim delta, about 400 miles northwest of Anchorage. It is in this special and isolated community where I practice as a dental therapist, trained and certified to deliver some, but not all, types of dental care. Dental therapists have been practicing in Alaska for nine years and now provide routine dental care to 40,000 Native Alaskans. In the United States about forty-seven million people live in areas where there is a shortage of dentists, and millions more can't afford to see them. For so many Americans, even the most basic dental care is out of reach. Yet right here in Alaska, I think we've found part of the solution (Conan Murat, November, 2013).
HealthCom Media, a leading information and content development company specializing in marketing and publishing solutions that complement traditional advertising programs.
New data presented at the 2016 San Antonio Breast Cancer Symposium (SABCS) demonstrate that analyzing tumor biology with the Oncotype DX test can identify patients unlikely to benefit from chemotherapy prior to breast cancer surgery (neoadjuvant setting) and guide treatment decisions without compromising outcomes.
› Verified 6 days ago
Dr. Alita Logrono Dizon, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 377 Jersey Ave, Suite 460, Jersey City, NJ 07302 Phone: 201-332-4110 Fax: 201-332-4122 | |
Mrs. Sonia Castaneda Velasco, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 172 Newark Ave, Jersey City, NJ 07302 Phone: 201-332-4727 Fax: 201-332-4157 | |
Dr. Vladimir Znamensky, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 120 Franklin St, Jersey City, NJ 07307 Phone: 201-216-9791 Fax: 201-216-1362 | |
Saira Shah, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 355 Grand St, Medicine Dept,3rd Floor, Jersey City, NJ 07302 Phone: 201-915-2000 | |
Zorayda Olaya De Leon, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 311 Palisade Ave, Jersey City, NJ 07307 Phone: 201-963-5500 Fax: 201-963-5563 | |
Dr. Jared Saul Krok, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 355 Grand St, Jersey City, NJ 07302 Phone: 201-915-2431 | |
Merwin F Richard, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 550 Newark Ave, Ste 307, Jersey City, NJ 07306 Phone: 201-418-9111 Fax: 201-418-9118 |